FDA Inspection 1077757 — Orient Pharma Co., Ltd.
The FDA completed an inspection of Orient Pharma Co., Ltd. on November 16, 2018 in Yunlin County. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 16, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yunlin County (Taiwan)